Hereditary Haemorrhagic Telangiectasia - delineation of the different phenotypes caused by endoglin and ALK1 mutation.

被引：0
|
作者：
Berg, J
Porteous, M
Reinhardt, D
Holloway, S
Gallione, C
Lux, A
McKinnon, W
Guttmacher, A
Marchuk, D
机构：
[1] GKT, Sch Med, Div Med & Mol Genet, London, England
[2] Western Gen Hosp, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Duke Univ, Sch Med, Dept Genet, Durham, NC 27706 USA
[4] Inst Mol Biol Zelikulturtech, Mannheim, Germany
[5] Vermont Reg Genet Ctr, Burlington, VT USA
[6] NHGRI, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
584
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [1] Hereditary haemorrhagic telangiectasia - the different phenotypes caused by endoglin and ALK1 mutation
    Berg, J
    Marchuk, D
    Guttmacher, A
    Porteous, M
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S29 - S29
  • [2] Hereditary haemorrhagic telangiectasia:: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations
    Berg, J
    Porteous, M
    Reinhardt, D
    Gallione, C
    Holloway, S
    Umasunthar, T
    Lux, A
    McKinnon, W
    Marchuk, D
    Guttmacher, A
    JOURNAL OF MEDICAL GENETICS, 2003, 40 (08) : 585 - 590
  • [3] Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia
    Ruiz-Llorente, Lidia
    Gallardo-Vara, Eunate
    Rossi, Elisa
    Smadja, David M.
    Botella, Luisa M.
    Bernabeu, Carmelo
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (10) : 933 - 947
  • [4] Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells
    Albinana, Virginia
    Bernabeu-Herrero, Maria E.
    Zarrabeitia, Roberto
    Bernabeu, Carmelo
    Botella, Luisa M.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (03) : 525 - 534
  • [5] Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia
    Smoot, L. B.
    Obler, D.
    McElhinney, D. B.
    Boardman, K.
    Wu, B-L
    Lip, V.
    Mullen, M. P.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (07) : 506 - 511
  • [6] Hereditary Haemorrhagic Telangiectasia: ENG and ALK1 mutations in Dutch patients.
    Letteboer, TGW
    Zewald, RA
    Mager, JJ
    Westermann, CJJ
    van Amstel, JKP
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 522 - 522
  • [7] Clinical phenotypes, ALK1 gene mutation and level of related plasma proteins in Chinese hereditary hemorrhagic telangiectasia
    Zhang, GS
    Yi, Y
    Peng, HL
    Shen, JK
    Xie, DH
    He, XB
    CHINESE MEDICAL JOURNAL, 2004, 117 (06) : 808 - 812
  • [8] Distinct angiostatic lung profile in endoglin and ALK1 mouse models of hereditary hemorrhagic telangiectasia
    Ardelean, Daniela S.
    Jerkic, Mirjana
    Peter, Madonna
    Ngan, Bo
    Kerbel, Robert S.
    Letarte, Michelle
    ANGIOGENESIS, 2015, 18 (04) : 571 - 571
  • [9] Clinical phenotypes,ALK1 gene mutation and level of related plasma proteins in Chinese hereditary hemorrhagic telangiectasia
    张广森
    易彦
    彭宏凌
    申建凯
    谢鼎华
    贺湘波
    中华医学杂志(英文版), 2004, (06) : 8 - 12
  • [10] Clinical phenotypes,ALK1 gene mutation and level of related plasma proteins in Chinese hereditary hemorrhagic telangiectasia
    张广森
    易彦
    彭宏凌
    申建凯
    谢鼎华
    贺湘波
    ChineseMedicalJournal, 2004, (06)
12345